We are pleased to be onsite with the European liver community at the Paris Hepatology Conference discussing the impact of Primary Biliary Cholangitis (PBC). For more information, visit: bit.ly/49R2991 #HybridPHC2024

Today we become a wholly owned subsidiary of Gilead Sciences. We’ve always been dedicated to advancing life-changing treatments, and together we’ll be able to further our commitment to improve the lives of people with liver disease. bit.ly/3TKiEOz

We are pleased to be onsite at the CLDFoundation #LiverConnect Conference to discuss the latest research in #PrimaryBiliaryCholangitis. Check out the program: bit.ly/3IKpw8b

#DYK that more than 50% of people with autoimmune diseases, like #PrimaryBiliaryCholangitis (PBC), can experience depression and anxiety? Learn more about the importance of holistic health approaches for people with PBC: bit.ly/3Jh1TEz

At the #pbcSummit we joined advocates from around the world working to improve the lives of people with #PrimaryBiliaryCholangitis. Their passion and ideas inspired us and we left with lots to consider for our work ahead. Thank you PBC Foundation for leading this impactful event!

“Empowering Connections in PBC” was the theme at this year's PBCers Organization conference. Onsite we learned from people living with #PrimaryBiliaryCholangitis and their families and were so inspired by their stories. For resources on getting support, please visit: bit.ly/3xzzSFH

On #WorldLiverDay, we recognize the liver's central role in a myriad of vital functions in the body. With chronic liver disease on the rise, education surrounding #LiverHealth is so important. Watch to learn more about #PrimaryBiliaryCholangitis, a rare liver disease.

Last week, we welcomed some new recruits to our team on #BringYourChildToWorkDay. It was a day full of fun activities and #STEM experiments to inspire us all. They did a great job in their final presentation!

This #WomensHealthMonth, we encourage women to prioritize their #LiverHealth and speak up if experiencing itch or fatigue, symptoms of #PrimaryBiliaryCholangitis, a chronic, autoimmune liver disease. Learn more here: bit.ly/47LQ96P

At Digestive Disease Week #DDW2024, we will share results from our ongoing ASSURE study demonstrating further evidence of the efficacy and safety profile of our investigational therapy for #PrimaryBiliaryCholangitis. Learn more: bit.ly/3ymaQKK

On #ClinicalTrialsDay we join ACRP - Assoc. of Clinical Research Profession to recognize the critical progress made by clinical research and thank every participant that has taken part in a clinical study to help advance care in #PrimaryBiliaryCholangitis. Learn about our ongoing studies: bit.ly/3ypaD9u

We are proud to present our latest research in primary biliary cholangitis at #EASLCongress 2024 as part of Gilead’s research across liver diseases. Learn more at: bit.ly/3UMVUg6

Thank you Digestive Disease Week for another impactful meeting. It was great to connect with experts from across the U.S. passionate about advancing care for people living with #LiverDiseases and #PrimaryBiliaryCholangitis. #DDW2024

We are looking forward to #EASLCongress 2024 next week and meeting with hepatology experts from around the world as we work to advance care for people living with #PrimaryBiliaryCholangitis. Please visit: bit.ly/3QV9n4d

The myth that #PrimaryBiliaryCholangitis doesn’t impact men can delay diagnosis. This #MensHealthMonth, we encourage men to prioritize their #LiverHealth by talking to a doctor if experiencing common PBC symptoms like intense itch or fatigue. Learn more: bit.ly/4e7bbkH

At EASLnews #EASLCongress, we will share interim long-term data from our ASSURE study of our investigational therapy in people living with #PrimaryBiliaryCholangitis. Learn more: bit.ly/4eadqnl

As #EASLCongress closes, we are grateful to have shared our latest findings and connected with stakeholders from across #PrimaryBiliaryCholangitis and #hepatology as we continue working to improve PBC care. Thanks, EASLnews, for bringing this incredible community together!

Learn more about the unmet needs in #PrimaryBiliaryCholangitis today and how Gilead Sciences is working to create a healthier future for people living with #PBC and #LiverDisease.

Primary biliary cholangitis (PBC) is a rare, chronic, autoimmune liver disease that progressively destroys the liver’s bile ducts. Learn more about PBC here: bit.ly/3KRMfjT